Pink SheetThe US FDA’s May 2024 calendar of user fee goal dates is slight in comparison to the coming wave of applications with June goal dates, but what the range of pending applications makes up for what it m
ScripThe global non-profit Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which provides funding and other support for early-stage development of treatments, diagnostics an
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Partners With Century On Cancer
ScripInitial public offerings for US biopharmaceutical companies generally slowed as 2021 drew to a close and biotechnology stock valuations continued to fall below broader stock indices. Nevertheless, thr